0001104659-23-006677.txt : 20230126 0001104659-23-006677.hdr.sgml : 20230126 20230126060337 ACCESSION NUMBER: 0001104659-23-006677 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230125 FILED AS OF DATE: 20230126 DATE AS OF CHANGE: 20230126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHALLCROSS STEVEN A CENTRAL INDEX KEY: 0001263501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 23553824 BUSINESS ADDRESS: STREET 1: C/O ELYS GAME TECHNOLOGY CORP. STREET 2: 130 ADELAIDE STREET WEST, SUITE 701 CITY: TORONTO STATE: A6 ZIP: M5H2K4 BUSINESS PHONE: 301 944 6600 MAIL ADDRESS: STREET 1: C/O ELYS GAME TECHNOLOGY CORP. STREET 2: 130 ADELAIDE STREET WEST, SUITE 701 CITY: TORONTO STATE: A6 ZIP: M5H2K4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theriva Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9605 MEDICAL CENTER DRIVE STREET 2: SUITE 270 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 9605 MEDICAL CENTER DRIVE STREET 2: SUITE 270 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Synthetic Biologics, Inc. DATE OF NAME CHANGE: 20120305 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 4 1 tm234482-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-25 0 0000894158 Theriva Biologics, Inc. TOVX 0001263501 SHALLCROSS STEVEN A C/O THERIVA BIOLOGICS, INC.,, 9605, MEDICAL CENTER DRIVE, SUITE 270 ROCKVILLE MD 20850 1 1 0 0 CEO and CFO Common Stock 2023-01-25 4 P 0 25000 0.873 A 160000 D The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.860 through $0.875, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Steven A. Shallcross 2023-01-26